Daniel K. Spiegelman - Jun 10, 2025 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Elizabeth Keiley, as Attorney-in-fact
Stock symbol
VTVT
Transactions as of
Jun 10, 2025
Transactions value $
$66,360
Form type
4
Date filed
6/12/2025, 04:28 PM
Previous filing
Jun 2, 2025
Next filing
Jul 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SPIEGELMAN DANIEL K Director C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT /s/ Elizabeth Keiley, as Attorney-in-fact 2025-06-12 0001238403

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTVT Director stock option (right to buy) Award $66.4K +4K +66.67% $16.59 10K Jun 10, 2025 Class A Common Stock 4K $16.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of June 10, 2026, and the date of the 2026 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting.